Abstract:Background Micro- and macrovascular complications are a major burden for individuals with diabetes and can already arise in a prediabetic state. To allocate effective treatments and to possibly prevent these complications, identification of those at risk is essential. Objective This study aimed to build machine learning (ML) models that predict the risk of developing a micro- or macrovascular complication in individuals with prediabetes or diabetes. Methods In this study, we used electronic health records from Israel that contain information about demographics, biomarkers, medications, and disease codes; span from 2003 to 2013; and were queried to identify individuals with prediabetes or diabetes in 2008. Subsequently, we aimed to predict which of these individuals developed a micro- or macrovascular complication within the next 5 years. We included 3 microvascular complications: retinopathy, nephropathy, and neuropathy. In addition, we considered 3 macrovascular complications: peripheral vascular disease (PVD), cerebrovascular disease (CeVD), and cardiovascular disease (CVD). Complications were identified via disease codes, and, for nephropathy, the estimated glomerular filtration rate and albuminuria were considered additionally. Inclusion criteria were complete information on age and sex and on disease codes (or measurements of estimated glomerular filtration rate and albuminuria for nephropathy) until 2013 to account for patient dropout. Exclusion criteria for predicting a complication were diagnosis of this specific complication before or in 2008. In total, 105 predictors from demographics, biomarkers, medications, and disease codes were used to build the ML models. We compared 2 ML models: logistic regression and gradient-boosted decision trees (GBDTs). To explain the predictions of the GBDTs, we calculated Shapley additive explanations values. Results Overall, 13,904 and 4259 individuals with prediabetes and diabetes, respectively, were identified in our underlying data set. For individuals with prediabetes, the areas under the receiver operating characteristic curve for logistic regression and GBDTs were, respectively, 0.657 and 0.681 (retinopathy), 0.807 and 0.815 (nephropathy), 0.727 and 0.706 (neuropathy), 0.730 and 0.727 (PVD), 0.687 and 0.693 (CeVD), and 0.707 and 0.705 (CVD); for individuals with diabetes, the areas under the receiver operating characteristic curve were, respectively, 0.673 and 0.726 (retinopathy), 0.763 and 0.775 (nephropathy), 0.745 and 0.771 (neuropathy), 0.698 and 0.715 (PVD), 0.651 and 0.646 (CeVD), and 0.686 and 0.680 (CVD). Overall, the prediction performance is comparable for logistic regression and GBDTs. The Shapley additive explanations values showed that increased levels of blood glucose, glycated hemoglobin, and serum creatinine are risk factors for microvascular complications. Age and hypertension were associated with an elevated risk for macrovascular complications. Conclusions Our ML models allow for an identification of individuals with prediabetes or diabetes who are at increased risk of developing micro- or macrovascular complications. The prediction performance varied across complications and target populations but was in an acceptable range for most prediction tasks.

Prediction of complications in diabetes mellitus using machine learning models with transplanted topic model features

Machine Learning Approaches to Predict Risks of Diabetic Complications and Poor Glycemic Control in Nonadherent Type 2 Diabetes.

Predicting the onset of diabetes-related complications after a diabetes diagnosis with machine learning algorithms

Predicting Diabetes Mellitus With Machine Learning Techniques.

A Machine Learning Approach for Prediction of Diabetes Mellitus

Diabetes Mellitus Prediction using Machine Learning

Machine learning-based prediction of diabetic patients using blood routine data

A 10-year retrospective cohort of diabetic patients in a large medical institution: Utilizing multiple machine learning models for diabetic kidney disease prediction

Machine learning based predictive model of Type 2 diabetes complications using Malaysian National Diabetes Registry: A study protocol

Prediction of Diabetes using Machine Learning

An enhanced machine learning algorithm for type 2 diabetes prognosis with a detailed examination of Key correlates

Predicting diabetic retinopathy and identifying interpretable biomedical features using machine learning algorithms

Explainable Machine Learning-Based Prediction Model for Diabetic Nephropathy

Prediction of Diabetes Progress Based on Machine Learning Approach

Machine Learning-Based Prediction for High Health Care Utilizers by Using a Multi-Institutional Diabetes Registry: Model Training and Evaluation

Diabetes mellitus prediction using machine learning within the scope of a generic framework

Research on Diabetes Risk Prediction Model at Early Stage Based on Machine Learning

Machine Learning Approaches for Type 2 Diabetes Prediction and Care Management

1290-P: Developing Machine Learning Model for Predicting Acute Coronary Syndrome in Type 2 Diabetes Mellitus Patients through Substitution of Propensity Scores for Binary Variables

Machine Learning for Predicting Micro- and Macrovascular Complications in Individuals With Prediabetes or Diabetes: Retrospective Cohort Study

Prediction model for cardiovascular disease in patients with diabetes using machine learning derived and validated in two independent Korean cohorts